From: A Marfan syndrome gene expression phenotype in cultured skin fibroblasts
 | MFS Affected (known mutations) | Unaffected Controls (UC) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Subject | Sex | Age | Mutation | Platform | Ref. | Subject | Sex | Age | Platform |  | |||
1 | FB 969 | F | 53 | C628X | A | T | 30 | UC | 1 | F | 74 | Â | T | Â |
2 | FB 992 | M | 49 | R861X | A | T | 30 | UC | 2 | F | 34 | Â | T | Â |
3 | GD 1051 | F | 45 | PTC ex 24 | A | T | DMUP | UC | 3 | F | 34 | A | T | Â |
4 | FB 1234 | F | 34 | N1157X | A | T | 30 | UC | 4 | F | 34 | A | T | Â |
5 | FB 773 | F | 48 | D1191X | A | T | 30,61 | UC | 5 | F | 38 | A | T | Â |
6 | FB 857 | M | 16 | R1192X | Â | T | 30 | UC | 6 | F | 35 | A | T | Â |
7 | FB 751 | F | 54 | L1412X | Â | T | 30 | UC | 7 | F | 15 | A | T | Â |
8 | FB 997 | F | 48 | R1523X | Â | T | 30 | UC | 8 | F | 11 | A | Â | Â |
9 | FB 1286 | F | 33 | R2057X | A | T | 30 | UC | 9 | F | 5 | A | Â | Â |
10 | FR 60 | M | 7 | PTC ex 63 | A | T | DMUP | UC | 10 | F | 25 | A | T | Â |
11 | GD 021 | M | 17 | PTC ex 63 | A | T | DMUP | UC | 11 | F | 49 | A | Â | Â |
12 | GD 032 | F | 9 | PTC ex 64 | A | Â | DMUP | UC | 12 | F | 40 | A | Â | Â |
13 | FB 836 | F | 31 | C832Y | A | T | 8,61 | UC | 13 | M | 72 | A | T | Â |
14 | FB 837 | M | 10 | C832Y | A | T | 8,61 | UC | 14 | M | 49 | A | T | Â |
15 | FB 783 | F | 33 | C1117Y | A | T | 61 | UC | 15 | M | 36 | A | T | Â |
16 | FB 984 | M | 22 | C1171R | Â | T | 8 | UC | 16 | M | 43 | A | T | Â |
17 | FB 1069 | F | 4 | C1326R | Â | T | 8 | UC | 17 | M | 35 | A | T | Â |
18 | FB 1040 | F | 29 | C1361Y | A | T | 8 | UC | 18 | M | 15 | A | T | Â |
19 | FB 882 | F | 27 | C1402W | Â | T | 8 | UC | 19 | M | 71 | A | T | Â |
20 | FB 881 | M | 24 | C1589F | A | T | 61 | UC | 20 | M | 14 | A | T | Â |
21 | FB 1627 | M | 34 | C2038Y | A | T | UFUP | UC | 21 | M | 50 | A | Â | Â |
22 | FB 829 | M | 21 | C2053F | Â | T | 62 | Â | Â | Â | Â | Â | Â | Â |
23 | FB 1211 | M | 20 | C2111R | A | T | UFUP | Â | Â | Â | Â | Â | Â | Â |
24 | FB 1359 | M | 28 | C2686F | Â | T | 62 | Â | Â | Â | Â | Â | Â | Â |
25 | FB 890 | F | 4mo | del ex 44-46 | A | T | 63 | Â | Â | Â | Â | Â | Â | Â |
26 | FB 774 | F | 40 | del ex 42-43 | Â | T | 63 | Â | Â | Â | Â | Â | Â | Â |
27 | FB 970 | M | 38 | del ex 54 | Â | T | 63 | Â | Â | Â | Â | Â | Â | Â |
 | Average Age 29 | Average Age 37 | ||||||||||||
 | Additional MFS Affected (unknown mutations) | Additional Unaffected Controls (UC) | ||||||||||||
 | Subject | Sex | Age |  | Platform |  | Subject | Sex | Age | Platform |  | |||
28 | MFS 1 | M | 37 | AF | Â | T | Â | UC | 22 | M | 25 | Â | T | Â |
29 | MFS 3 | M | 25 | AF | Â | T | Â | UC | 23 | F | 56 | Â | T | Â |
30 | MFS 4 | F | 45 | AF | Â | T | Â | UC | 24 | M | 39 | Â | T | Â |
31 | MFS 5 | F | 68 | AF | Â | T | Â | UC | 25 | F | 38 | Â | T | Â |
32 | MFS 6 | M | 48 | AF | Â | T | Â | UC | 26 | F | 59 | Â | T | Â |
33 | MFS 7 | F | 29 | AF | Â | T | Â | UC | 27 | M | 30 | Â | T | Â |
34 | MFS >8 | M | 44 | AF | Â | T | Â | UC | 28 | M | 32 | Â | T | Â |
35 | MFS 9 | F | 55 | AF | Â | T | Â | UC | 29 | M | 55 | Â | T | Â |
36 | MFS 10 | F | 17 | AF | Â | T | Â | UC | 30 | M | 43 | Â | T | Â |
37 | MFS 11 | F | 42 | AF | Â | T | Â | UC | 31 | F | 58 | Â | T | Â |
38 | MFS 12 | M | 32 | AF | Â | T | Â | UC | 32 | F | 52 | Â | T | Â |
39 | MFS 13 | F | 47 | AF | Â | T | Â | UC | 33 | F | 23 | Â | T | Â |
40 | MFS 14 | M | 17 | AF | Â | T | Â | UC | 34 | F | 55 | Â | T | Â |
41 | MFS 17 | M | 53 | AF | Â | T | Â | UC | 35 | M | 38 | Â | T | Â |
42 | MFS 18 | M | 38 | AF | Â | T | Â | UC | 366 | F | 36 | Â | T | Â |
43 | MFS 20 | M | 46 | AF | Â | T | Â | UC | 37 | F | 41 | Â | T | Â |
 | Average Age 40 |  |  |  |  | Average Age 43 |  |  | ||||||
 |  |  |  |  | Total: | 17 |  | 42 |  |  |  | Total: | 19 | 32 |